Canada invests $17M in CRISM, creates new Atlantic Canada Node

The Government of Canada has made a $17M investment in the Canadian Research Initiative in Substance Misuse (CRISM). The funding, which comes from the Canadian Institutes of Health Research, will support a study of methamphetamine use in Canada and expand CRISM to a total of five regional Nodes. Quebec and Atlantic Canada will become two separate Nodes. The new Atlantic Node will be led by Dalhousie University clinical psychology and psychiatry researcher Sherry Stewart, and will receive $2.4M in funding to improve health outcomes for those who use substances. “This announcement represents a positive step forward in ensuring the Atlantic provinces are better prepared to meet the challenges of drug use and addiction,” said Dal VP Research and Innovation Alice Aiken. Canada| Dal Note: Archived stories may contain dead links or be missing source links.

Canada | Canada | Canada